v3.22.1
Condensed Balance Sheets - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash $ 36,611,167 $ 40,750,133
Accounts receivable 47,976 110,141
Prepaid research and development 565,301 107,000
Prepaid expenses and other current assets 1,165,072 1,502,725
Total assets 38,389,516 42,469,999
Current liabilities:    
Accounts payable 806,196 1,089,778
Accrued expenses and other current liabilities 3,574,001 2,715,761
Notes payable 0 248,911
Total liabilities 4,380,197 4,054,450
Commitments and contingencies (see Note 11)
Stockholders’ equity:    
Preferred stock, $0.001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding at March 31, 2022 and December 31, 2021
Common stock, $0.001 par value; 100,000,000 shares authorized; 25,227,051 and 25,155,198 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively. 25,227 25,155
Additional paid-in capital 68,442,380 68,208,081
Accumulated deficit (34,458,288) (29,817,687)
Total 34,009,319 38,415,549
Total liabilities and stockholders' equity $ 38,389,516 $ 42,469,999

Source